This session explores Takeda’s global approach to maintenance maturity, highlighting how one site advanced its performance across seven key pillars—from a 1.3 baseline score in 2022 to 2.6 in just two years. Through structured assessments across nine global sites, the program evaluated areas such as organization, reliability, cost calibration, and spare parts management. The session outlines concrete improvements made locally at one Takeda facility and how strategic focus—driven by decreased production volumes—enabled reliability-centered efforts to take root. In this session, you will learn more about how to:

• Structure and implement global maintenance maturity assessments across multiple sites.
• Drive site-level improvement by focusing on seven defined performance pillars.
• Align reliability efforts with changes in production strategy and asset availability.
• Translate maturity assessment data into actionable roadmaps.
• Sustain progress by embedding best practices into local operations and culture.

• How can pharmaceutical companies address the technical challenges associated with varying site maturities, such as different levels of automation and equipment sophistication, to enhance maintenance effectiveness?
• In what ways can cultural and regional differences affect the technical execution of maintenance tasks, and how can companies develop protocols that accommodate these differences while maintaining high standards?
• What techniques can be employed to optimize the use of predictive and preventive maintenance technologies across global sites, and how can these methods be adapted to local conditions and resource availability?
• How can organizations balance the need for rigorous compliance with cGMP standards and environmental regulations with the goal of streamlining maintenance processes and minimizing downtime?

In the Harvesting Session the World Café moderators will summarize the results of their discussions and highlight key findings.